At a minimum, results from all phase 35 clinical trials and any clinical trial results of significant medical importance should be submitted for publication.
But as more and more taxpayers fall into the clutches of the Alternative Minimum Tax, and credits and phase-outs proliferate, this old-fashioned ploy doesn't always work.